Seres Therapeutics, Inc. (MCRB) Total assets 2016–2025
Seres Therapeutics, Inc. (MCRB) total assets at each fiscal year-end, per SEC filings.
$138.2MFY2025 · since FY2016: $272.6M → $138.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $138.2M | -1.2% |
| FY2024 | $139.8M | -61.0% |
| FY2023 | $358.6M | +2.8% |
| FY2022 | $348.8M | -1.7% |
| FY2021 | $354.9M | +3.5% |
| FY2020 | $342.9M | +158.9% |
| FY2019 | $132.4M | +9.9% |
| FY2018 | $120.5M | -36.4% |
| FY2017 | $189.5M | -30.5% |
| FY2016 | $272.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MCRB financial trends
MCRB RevenueMCRB Net incomeMCRB Net marginMCRB Gross profitMCRB Gross marginMCRB Operating incomeMCRB Operating marginMCRB Operating cash flowMCRB Free cash flowMCRB Capital expendituresMCRB Return on equityMCRB Stock buybacksMCRB Dividends paidMCRB Total liabilitiesMCRB Shareholders’ equityMCRB overview →